Control of pancreatic exocrine secretion via muscarinic receptors: Which subtype(s) are involved? A review

Pancreatology

Volumn 3, Issue 4, 2003, Pages 284-292

  Niebergall Roth, Elke ^a   Singer, Manfred V ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

4 DAMP; Atropine; M1 receptor; M3 receptor; Pancreatic exocrine secretion; Pirenzepine; Telenzepine

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; AMYLASE; BICARBONATE; CHOLINERGIC RECEPTOR; MESSENGER RNA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M2 RECEPTOR; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OTENZEPAD; PANCREAS ENZYME; PIRENZEPINE; RECEPTOR SUBTYPE; TELENZEPINE;

ACINAR CELL; ANIMAL; CHOLINERGIC SYSTEM; CLASSIFICATION; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME RELEASE; ENZYMOLOGY; HUMAN; IC 50; NERVE ENDING; NONHUMAN; PANCREAS; PANCREAS DUCT; PANCREAS JUICE; PANCREAS SECRETION; PHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

EID: 0042173038     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000071766     Document Type: Article

References (61)

1. Singer MV: Neurohormonal control of pancreatic enzyme secretion in animals; in Go VLW (ed): The Pancreas: Biology, Pathobiology, and Diseases. New York, Raven, 1993, pp 425-448.
2. Solomon TE: Control of exocrine pancreatic secretion; in Johnson LR (ed): Physiology of the Gastrointestinal Tract. New York, Raven, 1994, pp 1499-1529.
3. Niebergall-Roth E, Krammer H-J, Radke R, Singer MV: Extrinsic and intrinsic innervation of the pancreas - mediators of pancreatic exocrine secretion. Z Gastroenterol 1997;35(suppl 2):47-57.
4. Whitcomb DC: Neuroendocrine control of the exocrine pancreas; in Greeley GH Jr (ed): Gastrointestinal Endocrinology. Totowa, Humana, 1999, pp 243-263.
5. Chey WY, Chang T-M: Neuronal hormonal regulation of exocrine pancreatic secretion. Pancreatology 2001;1:320-335.
6. Niebergall-Roth E, Singer MV: Central and peripheral neural control of pancreatic exocrine secretion. J Physiol Pharmacol 2001;52:523-538.
7. Debas HT, Yamagishi Z: Evidence for pyloropancreatic reflex for pancreatic exocrine secretion. Am J Physiol 1978;234:E468-E471.
8. Singer MV, Solomon TE, Wood J, Grossman MI: Latency of pancreatic enzyme response to intraduodenal stimulants. Am J Physiol 1980;238:G23-G29.
9. Singer MV: Latency of pancreatic fluid secretory response to intestinal stimulants in the dog. J Physiol 1983;339:75-85.
10. Wess J: Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 1996;10:69-99.
11. Caulfield MP, Birdsall NJM: International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 1998;2:279-290.
12. Hammer R, Berrie CP, Birdsall NJ, Burgen AS, Hulme EC: Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 1980;283:90-92.
13. Doods HN, Mathy MJ, Davidesko D, van Charldorp KJ, de Jonge A, van Zwieten PA: Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors. J Pharmacol Exp Ther 1987;242:257-262.
14. Goyal RK: Muscarinic receptor subtypes. Physiology and clinical implications. N Engl J Med 1989;321:1022-1029.
15. Giachetti A, Micheletti R, Montagna E: Cardioselective profile of AF-DX 116, a muscarinic M2 receptor antagonist. Life Sci 1986;38:1663-1672.
16. Hammer H, Giraldo E, Schiavi GB, Monferini E, Ladinsky H: Binding profile of a novel cardioselective muscarinic receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat. Life Sci 1986;38:1653-1662.
17. Gilbert R, Rattan S, Goyal RK: Pharmacological identification, activation and antagonism of two muscarinic receptor subtypes in the lower esophageal sphincter. J Pharmacol Exp Ther 1984;230:284-291.
18. Iwatsuki K, Horiuchi A, Yonekura H, Homma N, Naruta K, Chiba S: Subtypes of muscarinic receptors in pancreatic exocrine secretion in anesthetized dogs. Pancreas 1989;4:339-345.
19. Korc M, Ackerman MS, Roeske WR: A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini. J Pharmacol Exp Ther 1987;240:118-112.
20. Kato M, Ohkuma S, Kataoka K, Kashima K, Kuriyama K: Characterization of muscarinic receptor subtypes on rat pancreatic acini: Pharmacological identification by secretory responses and binding studies. Digestion 1992;52:194-203.
21. Eltze M, Gönne S, Riedel R, Schlotke B, Schudt C, Simon W: Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinergic drug. Eur J Pharmacol 1985;112:211-224.
22. Londong W, Londong V, Meierl A, Vorderholzer U: Telenzepine is at least 25 times more potent than pirenzepine - a dose response and comparative study in man. Gut 1987;28:888-895.
23. Riedel R, Bohnenkamp W, Eltze M, Heintze K, Prinz W, Kromer W: Comparison of the gastric antisecretory and antiulcer potencies of telenzepine, pirenzepine, ranitidine and cimetidine in the rat. Digestion 1988,40:25-32.
24. Coruzzi G, Adami M, Bertaccini G: Gastric antisecretory activity of telenzepine, a new M1-selective muscarinic antagonist: Comparison with pirenzepine. Arch Int Pharmacodyn Ther 1989;302:232-241.
25. Konturek SJ, Tasler J, Cieszkowski M, Szewczyk K, Kromer W: Comparison of telenzepine, pirenzepine and atropine on gastric acid and pepsin secretion in response to histamine, pentagastrin, bethanechol, sham-feeding and feeding. Digestion 1989;44:66-78.
26. Holtmann G, Küppers U, Singer MV: Telenzepine, a new M1-receptor antagonist, is a more potent inhibitor of pentagastrin-stimulated gastric acid output in dogs. Scand J Gastroenterol 1990;25:293-297.
27. Singer MV, Teyssen S, Küppers U: Influence of the M1 receptor antagonists telenzepine and pirenzepine on pancreatic secretory response to intraduodenal tryptophan in dogs. Digestion 1991;48:34-42.
28. Galvan M, Eltze M, Figal V: Telenzepine hydrochloride. Drugs of the future 1988;13:327-331.
29. Dehaye JP, Winand J, Hermans L, Poloczek P, Christophe J: Inhibitory effects of pirenzepine on muscarinic stimulation of rat pancreas. Eur J Pharmacol 1983;92:259-264.
30. Louie DS, Owyang C: Muscarinic receptor subtypes on rat pancreatic acini: Secretion and binding studies. Am J Physiol 1986;251:G275-G279.
31. 3H]-methylscopolamine. Nippon Shokakibyo Gakkai Zasshi 1991;88:1571-1578.
32. Van Zwam AJ, Willems PH, Rodriguez de Miranda JF, de Pont JJ, van Ginneken CA: Binding characteristics of the muscarinic receptor subtype in rabbit pancreas. J Recept Res 1990;10:119-135.
33. Otsuki M, Nakamura T, Okabayashi Y, Oka T, Fujii M, Baba S: Comparative inhibitoric effects of pirenzepine and atropine on cholinergic stimulation of exocrine and endocrine rat pancreas. Gastroenterology 1985;89:408-415.
34. Otsuki M, Okabayashi Y, Oka T, Nakamura T, Fujii M, Baba S: Pirenzepine inhibits pancreatic exocrine secretion in the rat. Pancreas 1986;1:443-448.
35. Jaworek J, Konturek SJ: Effects of pirenzepine and atropine on amylase response to various secretagogues from the rat pancreatic acini. Digestion 1987;36:175-181.
36. Konturek SJ, Jaworek J, Tasler J, Cieszkowski M, Yanaihara N: Subtypes of muscarinic receptors on canine pancreatic secretion in vivo and in vitro. Int J Pancreatol 1987;2:11-22.
37. Love JA, Szebeni K, Guillebeau Smith T: Veratridine-stimulated amylase secretion from rabbit pancreatic lobules: Role of cholinergic and noncholinergic receptors. Pancreas 1999;19:231-238.
38. Chariot J, de la Tour J, Vaille C, Roze C: Comparative effects of pirenzepine and atropine on pancreatic secretion in conscious rats. Arch Int Pharmacodyn Ther 1987;285:158-165.
39. Waelbroek M, Camus J, Winand J, Christophe J: Different antagonist binding of rat pancreatic and cardiac muscarinic receptors. Life Sci 1987;41:2235-2240.
40. Schmid SW, Modlin IM, Tang LH, Stoch A, Rhee S, Nathanson MH, Scheel GA, Gorelick FS: Telenzepine-sensitive muscarinic receptors on rat pancreatic acinar cells. Am J Physiol 1998;274:G734-G741.
41. Walker JA, Krehbiel CR, Harmon DL, St Jean G, Croom WJ Jr, Hagler WM Jr: Effects of slaframine and 4-diphenylacetoxy-N-methylpiperidine methiodide (4DAMP) on pancreatic exocrine secretion in the bovine. Can J Physiol Pharmacol 1994;72:39-44.
42. Nelson DK, Pieramico O, Dahmen G, Dominguez-Munoz JE, Malfertheiner P, Adler G: M1-muscarinic mechanisms regulate interdigestive cycling of motor and secretory activity in human upper gut. Dig Dis Sci 1996;41:2006-2015.
43. Nelson DK, Dahmen G, Dominguez-Munoz JE, Pieramico O, Malfertheiner P, Adler G: Endogenous and exogenous stimulation of human pancreatic secretion: Modulation via M1-muscarinic pathways. Gastroenterology 1994;105:A1043.
44. Nelson DK, Malfertheiner P, Dahmen G, Dominguez-Munoz JE, Pieramico O, Adler G: Regulation of exocrine and endocrine pancreas via M1-muscarinic pathways; in Singer MV, Ziegler R, Rohr G (eds): Gastrointestinal Tract and Endocrine System. Dordrecht, Kluwer, 1995, pp 570-574.
45. Teyssen S, Niebergall E, Chari ST, Singer MV: Comparison of two dose-response techniques to study the pancreatic secretory response to intraduodenal tryptophan in the absence and in the presence of the M1-receptor antagonist telenzepine. Pancreas 1995;10:368-373.
46. Teyssen S, Niebergall-Roth E, Rausch A, Beglinger C, Riepl RL, Chari S, Singer MV: Comparison of the effects of the M1-receptor antagonist telenzepine and the CCK-receptor antagonist loxiglumide on the pancreatic secretory response to intraduodenal tryptophan in dogs. Pancreas 1996;13:407-416.
47. Niebergall-Roth E, Teyssen S, Wetzel D, Hartel M, Beglinger C, Riepl RL, Singer MV: Effects of telenzepine and L-364,718 on canine pancreatic secretion before and after vagotomy. Am J Physiol 1997;272:G1550-G1559.
48. Niebergall-Roth E, Teyssen S, Singer MV: Blockade of M1 receptors has different effects on endogenously and exogenously stimulated pancreatic protein output in dogs; in Singer MV, Krammer H-J (eds): Neurogastroenterology. From the Basics to the Clinics. Dordrecht, Kluwer, 2000, pp 389-393.
49. Niebergall-Roth E, Teyssen S, Singer MV: Effects of M1 and CCK antagonists on latency of pancreatic amylase response to intestinal stimulants. Am J Physiol 2000;279:G411-G416.
50. Debas HT, Konturek SJ, Grossman MI: Effect of extragastric and truncal vagotomy on pancreatic secretion in dogs. Am J Physiol 1975;228:1172-1177.
51. Singer MV, Solomon TE, Grossman MI: Effect of atropine on secretion from intact and transplanted pancreas in dogs. Am J Physiol 1980;238:G18-G22.
52. Vazquez-Echarri J, Baumgärtner D, Singer MV: Dose-response effects of atropine on pancreatic secretory response to intestinal tryptophan in dogs. Am J Physiol 1986;251:G847-G851.
53. Otsuki M, Okabayashi Y, Nakamura T, Fujii M, Oka T, Tani S, Baba S: Inhibitory effects of pirenzepine on cholecystokinin and secretin stimulation on exocrine and endocrine rat pancreas. Dig Dis Sci 1987;32:1136-1144.
54. Chang RSL, Lotti VJ: Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. Proc Natl Acad Sci USA 1986;83:4923-4926.
55. Tobin G, Sjogren C: Prejunctional facilitatory and inhibitory modulation of parasympathetic nerve transmission in the rabbit urinary bladder. J Auton Nerv Syst 1998;68:153-156.
56. Tobin G: Presynaptic muscarinic receptor mechanisms and submandibular responses to stimulation of the parasympathetic innervation in bursts in rats. Auton Neurosci 2002;99:111-118.
57. Watson GE, Culp DJ: Muscarinic cholinergic receptor subtypes in rat sublingual glands. Am J Physiol 1994;266:C335-C342.
58. Watson EL, Abel PW, DiJulio D, Zeng W, Makoid M, Jacobson KL, Potter LT, Dowd FJ: Identification of muscarinic receptor subtypes in mouse parotid gland. Am J Physiol 1996;271:C905-C913.
59. Hootman SR, Zukerman H, Kovalcik SA: Muscarinic receptors in isolated guinea pig pancreatic ducts. Biochem Pharmacol 1993;46:291-296.
60. Huertas JR, Madrid JA, Martinez-Victoria E, Manas M, Mataic FJ: Comparative effect of truncal vagotomy and pirenzepine on post-prandial secretory response of exocrine pancreas in dogs. Fundam Clin Pharmacol 1992;6:59-65.
61. Niebergall-Roth E, Teyssen S, Hartel M, Beglinger C, Riepl RL, Singer MV: Pancreatic bicarbonate response to intraduodenal tryptophan in dogs. Int J Pancreatol 1998;371:270-286.